Nabriva Therapeutics plc Separation Agreements
7 Contracts & Agreements
- Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger (Filed With SEC on July 7, 2023)
- Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan (Filed With SEC on July 7, 2023)
- Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia (Filed With SEC on April 17, 2023)
- Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Steven Gelone (Filed With SEC on January 20, 2023)
- Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder (Filed With SEC on January 20, 2023)
- Transition, Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Colin Broom, dated as of July 23, 2018 (Filed With SEC on July 25, 2018)
- SEPARATION AND RELEASE OF CLAIMS AGREEMENT (Filed With SEC on August 31, 2017)
